InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
2
T+90 胜率
100%
T+90 平均收益
+12.1%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Leversage Jill, 董事. Insider active across 1 company, notably Aurinia Pharmaceuticals Inc.. In total, 7 disclosures have been published. Breakdown: 2 buys · 2 sells. Total volume traded: €131k. Activity tracked since 11 May 2021. The latest transaction was disclosed on 21 November 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Leversage Jill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
12,135 股0Common SharesSEC:0001600620-24-000124:0
5,610 股@ US$5.7416.3% 占其流量Common StockSEC:0001600620-24-000072:0
8,733 股Common StockSEC:0001600620-23-000017:0
4,815 股@ US$11.2627.7% 占其流量Common StockSEC:0001600620-23-000017:2
9,310 股0Common StockSEC:0001600620-23-000017:1
1,600 股@ US$20.0421.7% 占其流量Common StockSEC:0001628280-21-025130:0
标准退出：2022年3月13日 (T+90)
2,500 股@ US$10.955717.2% 占其流量Common StockSEC:0001628280-21-010018:0
标准退出：2021年8月9日 (T+90)
7 条申报中的 7 条
About Leversage Jill
Jill Leversage is a Board Member at Aurinia Pharmaceuticals Inc. She plays a key role in the governance of the company and in strategic decision-making. Her expertise in the pharmaceutical sector is valuable to the board.
